$11.65
0.898.27%
Last update: Nov 4, 7:28 PM
Ginkgo Bioworks Holdings Inc
DNANYSE
The average analyst price target for Ginkgo Bioworks Holdings is $48, 317.8% above the current price. Of 5 analysts, 2 rate it Hold and 3 Sell. Targets range from $5 to $120. The latest change came on Oct 13, 2026, when TD Cowen raised its price target on Ginkgo Bioworks Holdings from $9 to $11 and kept a Hold rating.
Price Target Range — 8 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
